Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.6K
3.6K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

3.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
1.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Designer polyQ fusion proteins sequester USP7/HDM2 for modulating P53 functionality.

iScience·2025
Same author

Coaggregation of polyglutamine (polyQ) proteins is mediated by polyQ-tract interactions and impairs cellular proteostasis.

Acta biochimica et biophysica Sinica·2023
Same author

PolyQ-expanded proteins impair cellular proteostasis of ataxin-3 through sequestering the co-chaperone HSJ1 into aggregates.

Scientific reports·2021
Same author

Author Correction: Structural and dynamic studies reveal that the Ala-rich region of ataxin-7 initiates α-helix formation of the polyQ tract but suppresses its aggregation.

Scientific reports·2020
Same author

Structural and dynamic studies reveal that the Ala-rich region of ataxin-7 initiates α-helix formation of the polyQ tract but suppresses its aggregation.

Scientific reports·2019
Same author

Emerging roles of sphingosylphosphorylcholine in modulating cardiovascular functions and diseases.

Acta pharmacologica Sinica·2018

Related Experiment Video

Updated: Mar 30, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

4.1K

Sphingosylphosphorylcholine in cancer progress.

Hong-Wei Yue1, Qing-Chuan Jing2, Ping-Ping Liu3

  • 1Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Science, Shandong University Jinan 250100, China.

International Journal of Clinical and Experimental Medicine
|November 10, 2015
PubMed
Summary

Sphingosylphosphorylcholine (SPC), a bioactive sphingolipid, plays a role in cell regulation. Elevated SPC levels in cancer ascites suggest its involvement in tumor progression, affecting cancer cell proliferation and migration.

Keywords:
GPCRsSphingosylphosphorylcholinecancersecond messenger

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K
Three-Dimensional 3D Tumor Spheroid Invasion Assay
12:19

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

60.1K

Related Experiment Videos

Last Updated: Mar 30, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

4.1K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K
Three-Dimensional 3D Tumor Spheroid Invasion Assay
12:19

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

60.1K

Area of Science:

  • Biochemistry and Molecular Biology
  • Oncology
  • Cellular Physiology

Background:

  • Sphingosylphosphorylcholine (SPC) is a bioactive sphingolipid found in blood plasma.
  • SPC functions as an intracellular second messenger and an extracellular agent via G protein-coupled receptors (GPCRs).
  • Elevated SPC levels are observed in the ascites of cancer patients, indicating a potential role in malignancy.

Purpose of the Study:

  • To review the current understanding of Sphingosylphosphorylcholine's role in tumor progression.
  • To explore the impact of SPC on the proliferation and migration of various cancer cell types.

Main Methods:

  • Literature review of existing research on Sphingosylphosphorylcholine and cancer.
  • Analysis of studies investigating SPC's effects on cancer cell behavior.

Main Results:

  • Sphingosylphosphorylcholine has been implicated in influencing the proliferation and migration of diverse cancer cells.
  • Specific cancer types affected include pancreatic, ovarian, glioma, neuroblastoma, melanoma, and leukemia cells.

Conclusions:

  • Sphingosylphosphorylcholine is a significant factor in cancer progression.
  • Further research into SPC's mechanisms in tumorigenesis is warranted.